Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling

References

• Meng S, Jian Z, Yan X, Li J, Zhang R. LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer. Mol Med Rep. 2019;20(3):2541–2548. doi:10.3892/mmr.2019.1051031322251
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• van der Werf A, Arthey K, Hiesmayr M, et al. The determinants of reduced dietary intake in hospitalised colorectal cancer patients. Support Care Cancer. 2018;26(6):2039–2047. doi:10.1007/s00520-018-4044-129352452
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.04222632970
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.02128985560
   PubMed Web of Science ®Google Scholar
• Nguyen THP, Mahalakshmi B, Velmurugan BK. Functional role of ferroptosis on cancers, activation and deactivation by various therapeutic candidates-an update. Chem Biol Interact. 2020;317:108930. doi:10.1016/j.cbi.2019.10893031866335
   PubMed Web of Science ®Google Scholar
• Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830–849. doi:10.1016/j.ccell.2019.04.00231105042
   PubMed Web of Science ®Google Scholar
• Shen LD, Qi WH, Bai JJ, et al. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation. Anat Rec. 10.
   Google Scholar
• Chen P, Li X, Zhang R, et al. Combinative treatment of beta-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10(11):5107–5119. doi:10.7150/thno.4470532308771
   PubMed Web of Science ®Google Scholar
• Scott AJ, Messersmith WA, Jimeno A. Apatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumors. Drugs Today (Barc). 2015;51(4):223–229. doi:10.1358/dot.2015.51.4.232059926020064
   PubMed Web of Science ®Google Scholar
• Ma JL, Zhang T, Suo FZ, et al. Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803. J Cell Biochem. 2018;119(6):4957–4966. doi:10.1002/jcb.2674129384217
   PubMed Web of Science ®Google Scholar
• Li A, Wang K, Xu A, et al. Apatinib as an optional treatment in metastatic colorectal cancer. Medicine (Baltimore). 2019;98(35):e16919. doi:10.1097/MD.000000000001691931464927
   PubMed Web of Science ®Google Scholar
• Liang L, Wang L, Zhu P, et al. A pilot study of apatinib as third-line treatment in patients with heavily treated metastatic colorectal cancer. Clin Colorectal Cancer. 2018;17(3):e443–e449. doi:10.1016/j.clcc.2018.02.01129576426
   PubMed Web of Science ®Google Scholar
• Cheng X, Feng H, Wu H, et al. Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer. Cancer Lett. 2018;431:105–114. doi:10.1016/j.canlet.2018.05.04629859300
   PubMed Web of Science ®Google Scholar
• Su YC, Feng YH, Wu HT, et al. Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression. Sci Rep. 2018;8(1):6586. doi:10.1038/s41598-018-24633-329700319
   PubMed Web of Science ®Google Scholar
• Feng YH, Chen WY, Kuo YH, et al. Elovl6 is a poor prognostic predictor in breast cancer. Oncol Lett. 2016;12(1):207–212. doi:10.3892/ol.2016.458727347126
   PubMed Web of Science ®Google Scholar
• Wang H, An P, Xie E, et al. Characterization of ferroptosis in murine models of hemochromatosis. Hepatology. 2017;66(2):449–465. doi:10.1002/hep.2911728195347
   PubMed Web of Science ®Google Scholar
• Chen Y, Li N, Wang H, et al. Amentoflavone suppresses cell proliferation and induces cell death through triggering autophagy-dependent ferroptosis in human glioma. Life Sci. 2020;247:117425. doi:10.1016/j.lfs.2020.11742532057904
   PubMed Web of Science ®Google Scholar
• Sang M, Luo R, Bai Y, et al. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Theranostics. 2019;9(21):6209–6223. doi:10.7150/thno.3628331534546
   PubMed Web of Science ®Google Scholar
• Sui XB, Zhang RN, Liu SP, et al. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol. 2018;9:8. doi:10.3389/fphar.2018.0137129449808
   PubMed Web of Science ®Google Scholar
• Bao WE, Liu XW, Lv YL, et al. Nanolongan with multiple on-demand conversions for ferroptosis-apoptosis combined anticancer therapy. ACS Nano. 2019;13(1):260–273. doi:10.1021/acsnano.8b0560230616348
   PubMed Web of Science ®Google Scholar
• Chen Y, Fan ZM, Yang Y, Gu CY. Iron metabolism and its contribution to cancer (Review). Int J Oncol. 2019;54(4):1143–1154. doi:10.3892/ijo.2019.472030968149
   PubMed Web of Science ®Google Scholar
• Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379. doi:10.1038/cdd.2015.15826794443
   PubMed Web of Science ®Google Scholar
• Dai E, Zhang W, Cong D, Kang R, Wang J, Tang D. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523(4):966–971. doi:10.1016/j.bbrc.2020.01.06631964528
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1–2):317–331. doi:10.1016/j.cell.2013.12.01024439385
   PubMed Web of Science ®Google Scholar
• Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966–4975. doi:10.1073/pnas.160324411327506793
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338–1343. doi:10.1016/j.bbrc.2016.08.12427565726
   PubMed Web of Science ®Google Scholar
• Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91–98. doi:10.1038/nchembio.223927842070
   PubMed Web of Science ®Google Scholar
• Imai H, Matsuoka M, Kumagai T, Sakamoto T, Koumura T. Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr Top Microbiol Immunol. 2017;403:143–170. doi:10.1007/82_2016_50828204974
   PubMed Web of Science ®Google Scholar
• Bai T, Lei PX, Zhou H, et al. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. J Cell Mol Med. 2019;23(11):7349–7359. doi:10.1111/jcmm.1459431507082
   PubMed Web of Science ®Google Scholar
• Li H, Wang XL, Tang J, Zhao HB, Duan M. Decreased expression levels of ELOVL6 indicate poor prognosis in hepatocellular carcinoma. Oncol Lett. 2019;18(6):6214–6220. doi:10.3892/ol.2019.1097431788097
   PubMed Web of Science ®Google Scholar
• Zakharova GS, Poloznikov AA, Astakhova LA, et al. The effect of ELOVL6 fatty acid elongase inhibition on the expression of genes associated with the metastasis of breast cancer. Russ Chem Bull. 2018;67(12):2307–2315. doi:10.1007/s11172-018-2374-2
   Web of Science ®Google Scholar
• Wong JM, Chi SN, Marcus KJ, et al. Germinoma with malignant transformation to nongerminomatous germ cell tumor. J Neurosurg Pediatr. 2010;6(3):295–298. doi:10.3171/2010.6.PEDS0954120809716
   PubMed Web of Science ®Google Scholar
• Cheng J, Fan YQ, Liu BH, Zhou H, Wang JM, Chen QX. ACSL4 suppresses glioma cells proliferation via activating ferroptosis. Oncol Rep. 2020;43(1):147–158. doi:10.3892/or.2019.741931789401
   PubMed Web of Science ®Google Scholar